2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Oncology Biomarkers Market?

The increasing number of cancer cases is predicted to drive the growth of the oncology biomarker market. Cancer is characterized by the uncontrolled and gradual expansion of certain cells throughout the body. Oncology biomarkers help classify cancers by examining genes, proteins, and other substances within an individual. For example, the National Library of Medicine, a U.S.-based governmental agency, forecasts that there will be 2,001,140 new cancer diagnoses and 611,720 cancer-related deaths in the U.S. in 2024. Furthermore, the rate of cervical cancer in people between the ages of 30 to 44, along with colorectal cancer in individuals below 55, has increased by 1%-2% annually among young adults. As a result, the upward trend of cancer will fuel the oncology biomarker market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12493&type=smp

How Will the Growth Rate of theOncology Biomarkers Market Impact Industry Trends by 2034?

The market size for oncology biomarkers has seen a swift expansion in the preceding years. The market which stood at $15.3 billion in 2024, is projected to increase to $17.43 billion in 2025, showing a compound annual growth rate (CAGR) of 13.9%. The significant growth during the previous period is a result of adoption in emerging economies, implementation of precision medicine initiatives, innovative diagnostic approaches, support in drug development, and a rise in the incidence of cancer.

The market size of oncology biomarkers is predicted to experience a swift expansion in the upcoming years, reaching a value of $29.64 billion by 2029 with a compound annual growth rate (CAGR) of 14.2%. The anticipated growth during the forecast period is due to factors like the incorporation of next-generation sequencing (ngs), broadening of biomarker informatics, emphasis on predictive pharmacogenomics, the quick progression of exosome-based biomarkers, and the implementation of spatial transcriptomics. The forecast period will also witness significant trends such as standardization and quality assurance measures, shift towards functional biomarkers, the critical role biomarkers play in clinical trials, wide-ranging applications in immunotherapy, and real-time monitoring of treatment responses.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12493

What New Market Trends Are Reshaping theOncology Biomarkers Market and Its Opportunities?

The incorporation of cutting-edge and innovative technologies constitutes a critical trend in the oncology biomarker market. Leading businesses within this market are leveraging novel technologies as an instrumental strategy to consolidate their standing. For instance, OncoDNA, a Belgium-based company specializing in precision oncology medicine, rolled out OncoDEEP, a groundbreaking kit in 2022. This distinctive kit enables laboratories to carry out wide-scale biomarker testing. OncoDEEP deploys Next-generation sequencing (NGS) technology, coupled with cloud-based software tools, to equip laboratories with the capacity to conduct large-panel sequencing. This enables them to procure the molecular characterization of a tumour, process the raw data, and tap into comprehensive quality controls.

Who Are the Leading Market Players Fueling Growth in the Oncology Biomarkers Market Trend?

Major companies operating in the oncology biomarkers market include F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol -Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

How is the Global Oncology Biomarkers Market Segemented?

The oncology biomarkers market covered in this report is segmented –

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers

2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)

3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12493&type=smp

Which Geographics are Influencing the Growth of the Oncology Biomarkers Market?

North America was the largest region in the oncology biomarkers market in 2024. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Oncology Biomarkers Maret 2025, By The Business Research Company:

Community Oncology Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/community-oncology-services-global-market-report

Immuno-Oncology Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Clinical Oncology Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: